微小(≤3 mm)未破裂大脑中动脉动脉瘤治疗的安全性与有效性:神经血管质量倡议-质量结局数据库脑动脉瘤登记分析
基于NVQI-QOD登记数据,674例治疗的未破裂大脑中动脉动脉瘤中57例(8.5%)为微小动脉瘤(最大径≤3 mm),平均宽度2.2 mm,平均年龄55.9岁,61.4%接受显微手术。术中并发症率5.3%,术后并发症率10.5%,出院时87.5%完全闭塞。作者认为治疗有效但并发症率可能较高,应谨慎决定是否治疗。
要点
- 微小未破裂大脑中动脉动脉瘤占治疗总数的8.5%(57/674),多数采用显微手术(61.4%)。
- 术中并发症率5.3%(3/57),术后并发症率10.5%(6/57),10.5%出院转康复机构。
- 出院时完全闭塞率87.5%(42/57),随访资料亚组出院mRS 0占48.3%(14/29),末次随访mRS 0占46.9%(15/32)。
核心结论
- 治疗微小未破裂大脑中动脉动脉瘤有效,但并发症率可能较高,医生决定治疗时应谨慎。
研究设计与样本
- 回顾性查询神经血管质量倡议-质量结局数据库(NVQI-QOD)登记,纳入接受治疗的微小未破裂大脑中动脉动脉瘤患者,微小定义为最大径≤3 mm,共57例。
主要发现
- 674例治疗的未破裂大脑中动脉动脉瘤中57例(8.5%)为微小动脉瘤,平均宽度2.2 mm,平均年龄55.9岁。
- 61.4%(35/57)的动脉瘤接受显微手术。
- 总体术中并发症率5.3%(3/57),术后并发症率10.5%(6/57),10.5%(6/57)患者出院转康复机构。
- 出院时42例(87.5%)治疗的动脉瘤完全闭塞。
- 有随访记录亚组中,出院时mRS 0占48.3%(14/29),末次随访mRS 0占46.9%(15/32),中位随访166天。
关键数值与推荐
- 微小动脉瘤定义为最大径≤3 mm。
- 结局指标包括出院和末次随访改良Rankin量表评分(mRS)以及出院时动脉瘤闭塞状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Improved imaging modalities have led to an increased detection of intracranial aneurysms, many of which are small. There is uncertainty in the appropriate management of tiny aneurysms. The objective of this study was to use a large, multi-institutional NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) to assess the frequency, safety, and efficacy of treatment of tiny, unruptured middle cerebral artery (MCA) aneurysms. METHODS: The NeuroVascular Quality Initiative-Quality Outcomes Database registry was queried for patients with tiny unruptured MCA aneurysms who underwent treatment. Tiny size was defined as an aneurysm with a maximum dimension of ≤3 mm. Demographics, aneurysm characteristics, and treatment safety were queried. Outcomes included modified Rankin Score (mRS) at discharge and the last follow-up as well as aneurysm occlusion status at discharge. RESULTS: Of 674 treated, unruptured MCA aneurysms, 57 (8.5%) were tiny. The mean aneurysm width was 2.2 mm, and the mean patient age was 55.9 years. Most aneurysms were treated with microsurgery (61.4%, 35/57). The overall intraoperative complication rate was 5.3% (3/57), and the postoperative complication rate was 10.5% (6/57). 10.5% (6/57) of patients were discharged to rehabilitation. At discharge, 42 (87.5%) of the treated aneurysms had complete occlusion. In the subgroup of patients with recorded follow-up data, 48.3% (14/29) had a mRS of 0 at discharge and 46.9% (15/32) had an mRS of 0 at the last follow-up (median follow-up 166 days). CONCLUSION: Treatment of tiny, unruptured MCA aneurysms is efficacious but may have a high rate of complications. Physicians should be cautious when deciding to treat tiny, unruptured MCA aneurysms.
引用
- Padmanaban V, Harbaugh T, Zhu J, et al. Safety and Efficacy of Tiny (≤3 mm) Unruptured Middle Cerebral Artery Aneurysm Treatment: An Analysis of the NeuroVascular Quality Initiative-Quality Outcomes Database Cerebral Aneurysm Registry. Neurosurgery. 2024. PMID: 39570023. doi:10.1227/neu.0000000000003283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。